We are live on ! Find out more
DWTX

Dogwood Therapeutics
DWTX

14 hedge funds and large institutions have $5.58M invested in Dogwood Therapeutics in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $5.06M → $5.58M (+$525K)

0% more funds holding

Funds holding: 14 → 14 (0)

0% more ownership

Funds ownership: 0.42% → 0.43% (+0%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$800K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$105K
3
UBS Group
UBS Group
Switzerland
+$75.6K
4
VF
Virtu Financial
New York
+$74.3K
5
Citadel Advisors
Citadel Advisors
Florida
+$57.3K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$443K
2
PAM
PVG Asset Management
Colorado
-$316K
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$160K
4
Millennium Management
Millennium Management
New York
-$131K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$70.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
Masters Capital Management
Georgia
$3.77M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$887K +$800K +5,640 New
Two Sigma Investments
3
Two Sigma Investments
New York
$183K -$443K -3,128 -73%
Two Sigma Advisers
4
Two Sigma Advisers
New York
$155K -$70.3K -496 -33%
CA
5
Cetera Advisors
Colorado
$152K +$3.97K +28 +3%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$116K +$105K +740 New
UBS Group
7
UBS Group
Switzerland
$84K +$75.6K +533 New
VF
8
Virtu Financial
New York
$82K +$74.3K +524 New
Citadel Advisors
9
Citadel Advisors
Florida
$64K +$57.3K +404 New
BlackRock
10
BlackRock
New York
$61K +$50.6K +357 +1,231%
Osaic Holdings
11
Osaic Holdings
Arizona
$10K -$11.5K -81 -56%
TRCT
12
Tower Research Capital (TRC)
New York
$10K +$4.68K +33 +118%
Northwestern Mutual Wealth Management
13
Northwestern Mutual Wealth Management
Wisconsin
$5K +$4.25K +30 New
PAM
14
PVG Asset Management
Colorado
– -$316K -2,206 Closed
Envestnet Asset Management
15
Envestnet Asset Management
Illinois
– -$160K -1,114 Closed
Millennium Management
16
Millennium Management
New York
– -$131K -914 Closed
SFS
17
Sowell Financial Services
Arkansas
– -$15K -122 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$6K -40 Closed

DWTX Hedge Fund Activity: Q2 2021 in Review

14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2021, worth a combined $5.58M — up 10% from $5.06M a quarter earlier.

Fund positioning in DWTX was balanced in Q2 2021: 6 funds opened new positions, 6 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $800K. The largest seller was Two Sigma Investments, cutting an estimated $443K.

  • 14 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $5.58M of Dogwood Therapeutics stock for Q2 2021, up 10% quarter-over-quarter.
  • 6 funds opened new Dogwood Therapeutics positions in Q2 2021 and 6 closed out, a net change of 0 holders.
  • The largest Dogwood Therapeutics buyer in Q2 2021 was Vanguard Group, an estimated $800K added.
  • The largest Dogwood Therapeutics seller in Q2 2021 was Two Sigma Investments, an estimated $443K sold.

Based on aggregated 13F filings for Q2 2021.